STERLINBIO

Sterling Biotech Limited has informed the Exchange regarding Outcome of Board Meeting held on February 11, 2019.

Sterling Biotech Limited has informed the Exchange regarding Outcome of Meeting of Resolution Professional held on February 01, 2019.

Sterling Biotech Limited has informed the Exchange regarding Outcome of Board Meeting held on August 28, 2017.

Sterling Biotech Limited has informed the Exchange that the meeting of the Board of Directors of the Company held on September 02, 2016, in view to raise the resources for the purpose of meeting general corporate purposes, Augment the long term resources for long term financial needs of the Company including payment of over dues and refinancing of the existing debt, Board of Directors of the Company has recommended issue of unlisted 8% Redeemable Cumulative Non Participating and Non Convertible Preference Shares carrying no voting rights subject to consent of members of the Company and oth

Sterling Biotech Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on March 01, 2013 has considered and approved the following: (1) The Board of Directors has not recommended any dividend on the equity shares for the financial year ended December 31, 2012. (2) The Board has approved the resignation of Company Secretary of the Company Shri Kirtidev Khatri with effect from February 28, 2013.

Sterling Biotech Limited has informed the Exchange that at the Meeting of Board of Directors of the company held on June 25, 2008, the Board has approved issue of secured Non Convertible Debentures(NCD) on private placement basis to the extent of Rs. 300 Crores on such terms and conditions as may be mutually agreed upon with the lenders/ subscribers of the NCDs in compliance with the Guidelines issued by SEBI and other regulatory requirements for issue of Debentures.

Sterling Biotech Limited has informed the Exchange regarding the outcome of Board Meeting of the company held on February 07, 2008. The details of the business transacted at the Board Meeting shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Sterling_OutcomeBm_07022008.zip target=NEW> For more details click here.</a>

Sterling Biotech Limited has informed the Exchange that Board of Directors at their meeting held on September 16, 2005 decided, To convene an EGM of members on October 11, 2005. The EGM of the shareholder will consider passing enabling resolutions authorizing Board u/s 81(1) (A) of the Companies Act, 1956 for issue of Equity Shares / Warrants and / or any instrument convertible into Equity Shares, Global Depository Receipts (GDRs) / American Depository Receipts (ADRs) / FCCBs for an aggregate sum of US$ 50 million and authorizing the company to borrow up to Rs. 3000 crores in future as and wh

Sterling Biotech Limited has informed the Exchange that at the meeting of the BOD's of the Company held on February 07, 2005, the BOD's have decided to split the equity shares of face value of Rs.2/- each in to face value of Re.1/- each subject to approval of members at General Meeting of the Company. An EGM of members of the Company will be held on March 05, 2005 to consider split of shares in to face value of Re.1/- each and alteration of Capital Clause of Memorandum of Association of the Company.